EX-99.1
Puma Biotechnology Neratinib Product Launch - YouTube
FLASCO / FDA Clears Puma Biotechnology's Nerlynx for Extended Adjuvant Treatment of HER2-positive Early-Stage Breast Cancer
Why Puma Biotechnology (PBYI) Stock Is Surging Today - TheStreet
Puma Biotechnology: Profitable, Troubled, But Worth A Good Look (NASDAQ:PBYI) | Seeking Alpha
Why Puma Biotechnology, Inc. Stock Crashed 37% in March | The Motley Fool
HER2+ Breast Cancer Patients' Access to Neratinib Expanded Through Puma's EAP
LOOKING FORWARD
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News
A New Drug on the Horizon for HER2 Breast Cancer Patients | Avise Analytics
Puma's Nerlynx unleashed to fight HER2+ breast cancer with 'best case' label | Fierce Pharma
Puma Biotechnology Presents Final Results from the Biliary Tract Cohort of the Phase 2 SUMMIT 'Basket' Trial of Neratinib at the ASCO 2022 Annual Meeting | Business Wire
Puma Biotechnology
Cancer hopeful neratinib plagued by diarrhea, analysis shows, but Puma cites a solution | Fierce Pharma
Why Puma Biotechnology, Inc. Stock Crashed 37% in March
Puma Biotechnology
A New Drug on the Horizon for HER2 Breast Cancer Patients | Avise Analytics
Puma Biotechnology Presents Interim Results of Phase II CONTROL Trial of Neratinib in Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer at the 2019 SABCS | Business Wire
Pfizer Announces Agreement with Puma Biotechnology and Lyrica Success - Clinical Professionals
Puma Biotechnology Presents Updated Findings from the TBCRC-022 Trial at the 2022 San Antonio Breast Cancer Symposium | Business Wire
Puma Biotechnology Presents Interim Results of Phase II CONTROL Trial of Neratinib in Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer at the 2019 SABCS | Business Wire
Mission Accomplished – 365 Days on Nerlynx – Ela K. Browder
Puma Biotechnology Inc (PBYI) Stock Message Board | InvestorsHub
Puma Biotechnology reports interim SUMMIT results for neratinib | Drug Discovery News
